Reuters Events | Pharma

Thought leadership and innovation for the Pharmaceutical Industry

eyeforpharma, London (January 15, 2014): Gruntenthal UK believe that the continued survival of the pharmaceutical industry depends on successful KAM implementation, warning that its success hinges on buy-in from high level management and without their support your KAM approach is destined to fail.

The future of KAM lies in intensive co-operation between pharmaceutical companies and their stakeholders. KAM teams enable global company’s including Gruntenthal to work in a way that builds relationships and enables trust, trust being one of the fundamental pillars underpinning the future success of the pharma industry.

 In a recent Interview Allan Mackintosh, Senior Business Account Manager at Grunenthal UK described KAM implementation as “building a high level knowledge about your customer, the complex environment in which they operate and the challenges they face”.

This recent interview held by eyeforpharma investigates the practical complexities of implementing a KAM structure and how the correct approach can pay dividends.  The interview takes places in the build-up to the 12^th annual eyeforpharma Barcelona Summit which will also be looking at key account management in three key areas. Internal Planning, Customer segmentation, long-term communication strategy, all of which are set to build stronger relationships and value to your customer.

  “The movement towards a more business and customer focused approach within pharma continues and I’ll be looking to network with, and hear from, like-minded individuals who are determined to accelerate their organisation’s progress.  I hope to take away some key actions that will enable us to accelerate and improve our overall implementation of an innovative new approach to our business” said Allan Mackintosh of Grunenthal.

eyeforpharma Barcelona will be taking place 18-20^th March, 2014. For more information on the summit, to see who else will be in attendance, or to find out how this year’s agenda will influence your future business practices visit the official website.

For more information contact:

Lucy Fisher

EyeforPharma
(+44) 207-375-7225
lfisher@eyeforpharma.com